SwePub
Sök i SwePub databas

  Utökad sökning

Träfflista för sökning "WFRF:(Giordano Giuseppe) "

Sökning: WFRF:(Giordano Giuseppe)

  • Resultat 51-57 av 57
Sortera/gruppera träfflistan
   
NumreringReferensOmslagsbildHitta
51.
  • Shah, Nisha, et al. (författare)
  • Motivations for data sharing—views of research participants from four European countries : A DIRECT study
  • 2019
  • Ingår i: European Journal of Human Genetics. - : Springer Science and Business Media LLC. - 1018-4813 .- 1476-5438.
  • Tidskriftsartikel (refereegranskat)abstract
    • The purpose of this study was to explore and compare different countries in what motivated research participants’ decisions whether to share their de-identified data. We investigated European DIRECT (Diabetes Research on Patient Stratification) research project participants’ desire for control over sharing different types of their de-identified data, and with who data could be shared in the future after the project ends. A cross-sectional survey was disseminated among DIRECT project participants. The results found that there was a significant association between country and attitudes towards advancing research, protecting privacy, and beliefs about risks and benefits to sharing data. When given the choice to have control, some participants (<50% overall) indicated that having control over what data is shared and with whom was important; and control over what data types are shared was less important than respondents deciding who data are shared with. Danish respondents indicated higher odds of desire to control data types shared, and Dutch respondents showed higher odds of desire to control who data will be shared with. Overall, what research participants expect in terms of control over data sharing needs to be considered and aligned with sharing for future research and re-use of data. Our findings show that even with de-identified data, respondents prioritise privacy above all else. This study argues to move research participants from passive participation in biomedical research to considering their opinions about data sharing and control of de-identified biomedical data.
  •  
52.
  • Shah, Nisha, et al. (författare)
  • Sharing data for future research—engaging participants’ views about data governance beyond the original project : a DIRECT Study
  • 2019
  • Ingår i: Genetics in Medicine. - : Elsevier BV. - 1098-3600. ; 21:5, s. 1131-1138
  • Tidskriftsartikel (refereegranskat)abstract
    • Purpose: Biomedical data governance strategies should ensure that data are collected, stored, and used ethically and lawfully. However, research participants’ preferences for how data should be governed is least studied. The Diabetes Research on Patient Stratification (DIRECT) project collected substantial amounts of health and genetic information from patients at risk of, and with type II diabetes. We conducted a survey to understand participants’ future data governance preferences. Results will inform the postproject data governance strategy. Methods: A survey was distributed in Denmark, Sweden, The Netherlands, and the United Kingdom. Results: In total 855 surveys were returned. Ninety-seven percent were supportive of sharing data postproject, and 90% were happy to share data with universities, and 56% with commercial companies. The top three priorities for data sharing were highly secure database, DIRECT researchers to monitor data used by other researchers, and researchers cannot identify participants. Respondents frequently suggested that a postproject Data Access Committee should involve a DIRECT researcher, diabetes clinician, patient representative, and a DIRECT participant. Conclusion: Preferences of how data should be governed, and what data could be shared and with whom varied between countries. Researchers are considered as key custodians of participant data. Engaging participants aids in designing governance to support their choices.
  •  
53.
  • Slieker, Roderick C, et al. (författare)
  • Distinct Molecular Signatures of Clinical Clusters in People with Type 2 Diabetes : an IMIRHAPSODY Study
  • 2021
  • Ingår i: Diabetes. - : American Diabetes Association. - 1939-327X .- 0012-1797. ; 70:11, s. 2683-2693
  • Tidskriftsartikel (refereegranskat)abstract
    • Type 2 diabetes is a multifactorial disease with multiple underlying aetiologies. To address this heterogeneity a previous study clustered people with diabetes into five diabetes subtypes. The aim of the current study is to investigate the aetiology of these clusters by comparing their molecular signatures. In three independent cohorts, in total 15,940 individuals were clustered based on five clinical characteristics. In a subset, genetic- (N=12828), metabolomic- (N=2945), lipidomic- (N=2593) and proteomic (N=1170) data were obtained in plasma. In each datatype each cluster was compared with the other four clusters as the reference. The insulin resistant cluster showed the most distinct molecular signature, with higher BCAAs, DAG and TAG levels and aberrant protein levels in plasma enriched for proteins in the intracellular PI3K/Akt pathway. The obese cluster showed higher cytokines. A subset of the mild diabetes cluster with high HDL showed the most beneficial molecular profile with opposite effects to those seen in the insulin resistant cluster. This study showed that clustering people with type 2 diabetes can identify underlying molecular mechanisms related to pancreatic islets, liver, and adipose tissue metabolism. This provides novel biological insights into the diverse aetiological processes that would not be evident when type 2 diabetes is viewed as a homogeneous disease.
  •  
54.
  • Slieker, Roderick C, et al. (författare)
  • Identification of biomarkers for glycaemic deterioration in type 2 diabetes
  • 2023
  • Ingår i: Nature Communications. - 2041-1723. ; 14, s. 1-18
  • Tidskriftsartikel (refereegranskat)abstract
    • We identify biomarkers for disease progression in three type 2 diabetes cohorts encompassing 2,973 individuals across three molecular classes, metabolites, lipids and proteins. Homocitrulline, isoleucine and 2-aminoadipic acid, eight triacylglycerol species, and lowered sphingomyelin 42:2;2 levels are predictive of faster progression towards insulin requirement. Of ~1,300 proteins examined in two cohorts, levels of GDF15/MIC-1, IL-18Ra, CRELD1, NogoR, FAS, and ENPP7 are associated with faster progression, whilst SMAC/DIABLO, SPOCK1 and HEMK2 predict lower progression rates. In an external replication, proteins and lipids are associated with diabetes incidence and prevalence. NogoR/RTN4R injection improved glucose tolerance in high fat-fed male mice but impaired it in male db/db mice. High NogoR levels led to islet cell apoptosis, and IL-18R antagonised inflammatory IL-18 signalling towards nuclear factor kappa-B in vitro. This comprehensive, multi-disciplinary approach thus identifies biomarkers with potential prognostic utility, provides evidence for possible disease mechanisms, and identifies potential therapeutic avenues to slow diabetes progression.
  •  
55.
  • Slieker, Roderick C, et al. (författare)
  • Replication and cross-validation of type 2 diabetes subtypes based on clinical variables : an IMI-RHAPSODY study
  • 2021
  • Ingår i: Diabetologia. - : Springer Science and Business Media LLC. - 0012-186X .- 1432-0428. ; 64:9, s. 1982-1989
  • Tidskriftsartikel (refereegranskat)abstract
    • Aims/hypothesis: Five clusters based on clinical characteristics have been suggested as diabetes subtypes: one autoimmune and four subtypes of type 2 diabetes. In the current study we replicate and cross-validate these type 2 diabetes clusters in three large cohorts using variables readily measured in the clinic. Methods: In three independent cohorts, in total 15,940 individuals were clustered based on age, BMI, HbA1c, random or fasting C-peptide, and HDL-cholesterol. Clusters were cross-validated against the original clusters based on HOMA measures. In addition, between cohorts, clusters were cross-validated by re-assigning people based on each cohort’s cluster centres. Finally, we compared the time to insulin requirement for each cluster. Results: Five distinct type 2 diabetes clusters were identified and mapped back to the original four All New Diabetics in Scania (ANDIS) clusters. Using C-peptide and HDL-cholesterol instead of HOMA2-B and HOMA2-IR, three of the clusters mapped with high sensitivity (80.6–90.7%) to the previously identified severe insulin-deficient diabetes (SIDD), severe insulin-resistant diabetes (SIRD) and mild obesity-related diabetes (MOD) clusters. The previously described ANDIS mild age-related diabetes (MARD) cluster could be mapped to the two milder groups in our study: one characterised by high HDL-cholesterol (mild diabetes with high HDL-cholesterol [MDH] cluster), and the other not having any extreme characteristic (mild diabetes [MD]). When these two milder groups were combined, they mapped well to the previously labelled MARD cluster (sensitivity 79.1%). In the cross-validation between cohorts, particularly the SIDD and MDH clusters cross-validated well, with sensitivities ranging from 73.3% to 97.1%. SIRD and MD showed a lower sensitivity, ranging from 36.1% to 92.3%, where individuals shifted from SIRD to MD and vice versa. People belonging to the SIDD cluster showed the fastest progression towards insulin requirement, while the MDH cluster showed the slowest progression. Conclusions/interpretation: Clusters based on C-peptide instead of HOMA2 measures resemble those based on HOMA2 measures, especially for SIDD, SIRD and MOD. By adding HDL-cholesterol, the MARD cluster based upon HOMA2 measures resulted in the current clustering into two clusters, with one cluster having high HDL levels. Cross-validation between cohorts showed generally a good resemblance between cohorts. Together, our results show that the clustering based on clinical variables readily measured in the clinic (age, HbA1c, HDL-cholesterol, BMI and C-peptide) results in informative clusters that are representative of the original ANDIS clusters and stable across cohorts. Adding HDL-cholesterol to the clustering resulted in the identification of a cluster with very slow glycaemic deterioration. Graphical abstract: [Figure not available: see fulltext.]
  •  
56.
  • Tura, Andrea, et al. (författare)
  • Profiles of Glucose Metabolism in Different Prediabetes Phenotypes, Classified by Fasting Glycemia, 2-Hour OGTT, Glycated Hemoglobin, and 1-Hour OGTT : An IMI DIRECT Study
  • 2021
  • Ingår i: Diabetes. - : American Diabetes Association. - 1939-327X .- 0012-1797. ; 70:9, s. 2092-2106
  • Tidskriftsartikel (refereegranskat)abstract
    • Differences in glucose metabolism among categories of prediabetes have not been systematically investigated. In this longitudinal study, participants (N = 2,111) underwent a 2-h 75-g oral glucose tolerance test (OGTT) at baseline and 48 months. HbA1c was also measured. We classified participants as having isolated prediabetes defect (impaired fasting glucose [IFG], impaired glucose tolerance [IGT], or HbA1c indicative of prediabetes [IA1c]), two defects (IFG+IGT, IFG+IA1c, or IGT+IA1c), or all defects (IFG+IGT+IA1c). β-Cell function (BCF) and insulin sensitivity were assessed from OGTT. At baseline, in pooling of participants with isolated defects, they showed impairment in both BCF and insulin sensitivity compared with healthy control subjects. Pooled groups with two or three defects showed progressive further deterioration. Among groups with isolated defect, those with IGT showed lower insulin sensitivity, insulin secretion at reference glucose (ISRr), and insulin secretion potentiation (P < 0.002). Conversely, those with IA1c showed higher insulin sensitivity and ISRr (P < 0.0001). Among groups with two defects, we similarly found differences in both BCF and insulin sensitivity. At 48 months, we found higher type 2 diabetes incidence for progressively increasing number of prediabetes defects (odds ratio >2, P < 0.008). In conclusion, the prediabetes groups showed differences in type/degree of glucometabolic impairment. Compared with the pooled group with isolated defects, those with double or triple defect showed progressive differences in diabetes incidence.
  •  
57.
  • Wu, Cary, et al. (författare)
  • Chinese Citizen Satisfaction with Government Performance during COVID-19
  • 2021
  • Ingår i: Journal of Contemporary China. - : Informa UK Limited. - 1067-0564 .- 1469-9400. ; 30:132, s. 930-944
  • Tidskriftsartikel (refereegranskat)abstract
    • While foreign pundits have alternatively blamed and praised the Chinese government’s handling of the COVID-19 virus, little is known about how citizens within China understand this performance. This article considers how satisfied Chinese citizens are with their government’s performance during the COVID-19 pandemic. It first considers the impact of authoritarian control, political culture, and/or actual government performance on citizen satisfaction. Then, it tests the consequences of satisfaction and specifically whether citizen satisfaction leads to greater trust. Analyzing data from the first post-COVID survey of its kind (n = 19,816) conducted from April 22 to 28 April 2020, the authors find that Chinese citizens have an overall high level of satisfaction, but that this satisfaction drops with each lower level of government. Further, authoritarian control, political culture, and awareness of government performance all contribute to citizen satisfaction and this in turn, has enhanced public support for the Chinese government.
  •  
Skapa referenser, mejla, bekava och länka
  • Resultat 51-57 av 57
Typ av publikation
tidskriftsartikel (49)
konferensbidrag (3)
annan publikation (2)
doktorsavhandling (2)
forskningsöversikt (1)
Typ av innehåll
refereegranskat (52)
övrigt vetenskapligt/konstnärligt (4)
populärvet., debatt m.m. (1)
Författare/redaktör
Giordano, Giuseppe N ... (21)
Franks, Paul W. (16)
Lindström, Martin (11)
Pavo, Imre (9)
Schwenk, Jochen M. (8)
Ruetten, Hartmut (8)
visa fler...
Atabaki-Pasdar, Naei ... (7)
Koivula, Robert W (7)
Sjöberg, Jonas, 1964 (7)
Brunak, Søren (7)
McCarthy, Mark I (6)
Pedersen, Oluf (6)
Fitipaldi, Hugo (6)
Mari, Andrea (6)
Vinuela, Ana (6)
Mahajan, Anubha (6)
De Masi, Federico (6)
Kokkola, Tarja (6)
Walker, Mark (6)
Hansen, Torben (5)
‘t Hart, Leen M. (5)
Adamski, Jerzy (5)
Ridderstråle, Martin (4)
Laakso, Markku (4)
Kurbasic, Azra (4)
Bell, Jimmy D. (4)
Vestergaard, Henrik (4)
Heggie, Alison (4)
Kaye, Jane (4)
Forgie, Ian (4)
Pearson, Ewan (4)
Rutters, Femke (4)
Elders, Petra (4)
Teare, Harriet (4)
Tura, Andrea (4)
Lyssenko, Valeriya (3)
Groop, Leif (3)
Sundquist, Kristina (3)
Ahlqvist, Emma (3)
Rossing, Peter (3)
Sundquist, Jan (3)
Ali, Ashfaq (3)
Allin, Kristine H (3)
Suvitaival, Tommi (3)
Thomas, E. Louise (3)
Tajes, Juan Fernande ... (3)
Frost, Gary (3)
Dermitzakis, Emmanou ... (3)
Tsirigos, Konstantin ... (3)
Åkerlund, Mikael (3)
visa färre...
Lärosäte
Lunds universitet (45)
Umeå universitet (9)
Kungliga Tekniska Högskolan (9)
Chalmers tekniska högskola (9)
Uppsala universitet (6)
Stockholms universitet (4)
visa fler...
Karolinska Institutet (2)
Göteborgs universitet (1)
Högskolan i Halmstad (1)
Linköpings universitet (1)
Sveriges Lantbruksuniversitet (1)
visa färre...
Språk
Engelska (56)
Svenska (1)
Forskningsämne (UKÄ/SCB)
Medicin och hälsovetenskap (43)
Teknik (9)
Naturvetenskap (8)
Samhällsvetenskap (7)

År

Kungliga biblioteket hanterar dina personuppgifter i enlighet med EU:s dataskyddsförordning (2018), GDPR. Läs mer om hur det funkar här.
Så här hanterar KB dina uppgifter vid användning av denna tjänst.

 
pil uppåt Stäng

Kopiera och spara länken för att återkomma till aktuell vy